Device Trial Radar · NCT02813421
Continue Glucose Monitoring Before Insulin Pump
Last checked: Nov 20, 2026Latest source record: May 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11
Actual
Start
Mar 2016
Primary completion
May 1, 2017
Study completion May 1, 2017
Sponsor
- Lead sponsor
- Children's Hospital Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 27, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years, up to 24 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to learn more about blood glucose control when people with Type 1 Diabetes switch to an insulin pump. The investigators hope to learn whether using a continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to stable blood glucoses and less frequent insulin pump dose changes during the transition to an insulin pump.
Conditions
- Type 1 Diabetes Mellitus
Interventions
CGM InformedDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Time Within Target Blood Glucose (Range: 70-180 mg/dL)Time frame: First 6 weeks of insulin pump therapy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's Hospital Los Angeles
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.